Table 2 Median (25th, 75th percentile) SG-adjusted average urinary concentrations of exposure biomarkers (ng/mL) in the overall study population and according to case status

OPEs

BDCPP

0.67 (0.40, 1.09)

0.84 (0.33, 1.35)

0.79 (0.44, 1.12)

0.51 (0.35, 0.78)

0.14

DPhP

0.74 (0.52, 1.22)

0.72 (0.47, 1.60)

0.82 (0.70, 1.34)

0.60 (0.45, 0.89)

0.07

Phthalates

MEP

42.9 (14.5, 128)

41.1 (8.48, 188)

65.1 (28.7, 133)

26.4 (11.7, 60.0)

0.03

MBP

9.51 (6.81, 12.9)

9.99 (6.27, 17.9)

10.5 (7.14, 16.8)

8.36 (5.92, 10.5)

0.16

MBzP

3.27 (1.86, 6.85)

3.57 (1.89, 7.55)

2.68 (1.55, 5.88)

3.39 (1.88, 6.78)

0.78

MiBP

5.69 (4.04, 8.84)

5.73 (4.26, 9.24)

6.18 (3.78, 9.95)

5.47 (4.03, 7.08)

0.30

MECPP

9.17 (5.81, 15.9)

11.1 (5.87, 18.5)

9.37 (5.81, 17.7)

8.52 (4.76, 15.5)

0.56

MEHHP

6.31 (4.45, 10.9)

7.60 (5.26, 10.9)

5.30 (4.29, 11.1)

5.98 (3.92, 10.4)

0.24

MEOHP

4.44 (3.09, 7.88)

5.32 (3.26, 7.88)

3.77 (3.21, 8.02)

4.18 (2.58, 7.22)

0.58

MEHP

1.89 (1.16, 2.90)

2.28 (1.34, 3.09)

1.76 (1.02, 3.26)

1.68 (1.08, 2.59)

0.38

MCPP

2.24 (1.28, 4.50)

2.13 (1.13, 5.97)

2.47 (1.64, 5.23)

2.04 (1.08, 3.43)

0.42

MCOP

2.02 (1.09, 5.66)

3.45 (1.09, 5.25)

2.03 (1.17, 6.79)

1.73 (0.71, 4.82)

0.42

MCNP

0.30 (0.21, 0.46)

0.31 (0.23, 0.50)

0.31 (0.23, 0.48)

0.27 (0.17, 0.40)

0.36

Phenols

2,4-DCP

0.31 (0.21, 0.56)

0.31 (0.21, 0.60)

0.28 (0.21, 0.51)

0.37 (0.23, 0.57)

0.60

2.5-DCP

0.62 (0.42, 1.36)

0.79 (0.42, 1.45)

0.59 (0.43, 1.47)

0.57 (0.32, 1.18)

0.54

BP3

34.7 (12.3, 95.0)

45.6 (9.20, 95.0)

26.7 (13.7, 89.4)

44.0 (13.2, 128)

0.81

BPA

0.63 (0.48, 0.92)

0.59 (0.48, 0.99)

0.62 (0.42, 0.90)

0.74 (0.50, 1.01)

0.54

MPB

105 (37.3, 188)

125 (56.8, 204)

125 (76.4, 219)

37.0 (24.9, 170)

0.01

PPB

19.0 (7.07, 40.0)

18.6 (7.07, 50.7)

23.8 (12.1, 52.5)

10.7 (4.89, 29.6)

0.05

TCS

6.30 (2.09, 33.3)

4.24 (1.44, 44.1)

5.57 (1.61, 15.7)

12.3 (3.32, 52.4)

0.13